Glioblastoma - bevacizumab: final scope
Glioblastoma - bevacizumab: final matrix
Glioblastoma - bevacizumab: Institute's response to consultee and commentator comments on the draft scope
Glioblastoma - bevacizumab: Institute's response to consultee and commentator comments on the provisional matrix